Page last updated: 2024-11-04

sulfamethoxazole and Carcinoma, Transitional Cell

sulfamethoxazole has been researched along with Carcinoma, Transitional Cell in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeuchi, H1
Ozasa, Y1
Sasaki, S1
Oshima, M1

Other Studies

1 other study available for sulfamethoxazole and Carcinoma, Transitional Cell

ArticleYear
[A case of pneumocystis carinii pneumonia after chemotherapy of bladder tumor].
    Hinyokika kiyo. Acta urologica Japonica, 1985, Volume: 31, Issue:2

    Topics: Aged; Carcinoma, Transitional Cell; Doxorubicin; Drug Combinations; Humans; Male; Pneumonia, Pneumoc

1985